Alex K. Eapen
Cargill
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alex K. Eapen.
International Journal of Toxicology | 2008
Andrey I. Nikiforov; Alex K. Eapen
Rebaudioside A is one of several glycosides found in the leaves of Stevia rebaudiana (Bertoni) Bertoni (Compositae) stevia that has been identified as a potential sweetener. The present study (initiated in April 2006 and completed in October 2006) evaluated the safety of this sweetener when administered as a dietary admix at target exposure levels of 500, 1000, and 2000 mg/kg/day to Sprague-Dawley rats for 90 days. There were no treatment-related effects on the general condition and behavior of the animals as determined by clinical observations, functional observational battery, and locomotor activity assessments. Evaluation of clinical pathology parameters revealed no toxicologically relevant, treatment-related effects on hematology, serum chemistry, or urinalysis. Macroscopic and microscopic findings revealed no treatment-related effects on any organ evaluated. Lower mean body weight gains were noted in males in the 2000 mg/kg/day group throughout the study, which was considered to be test article related; however, given the small magnitude of the difference as compared to controls, this effect was not considered to be adverse. Results of this study clearly demonstrate that dietary administration of high concentrations of rebaudioside A for 90 consecutive days to Sprague-Dawley rats was not associated with any signs of toxicity.
International Journal of Dentistry | 2016
Peter de Cock; Kauko K. Mäkinen; Eino Honkala; Mare Saag; Elke Kennepohl; Alex K. Eapen
Objective. To provide a comprehensive overview of published evidence on the impact of erythritol, a noncaloric polyol bulk sweetener, on oral health. Methods. A literature review was conducted regarding the potential effects of erythritol on dental plaque (biofilm), dental caries, and periodontal therapy. The efficacy of erythritol on oral health was compared with xylitol and sorbitol. Results. Erythritol effectively decreased weight of dental plaque and adherence of common streptococcal oral bacteria to tooth surfaces, inhibited growth and activity of associated bacteria like S. mutans, decreased expression of bacterial genes involved in sucrose metabolism, reduced the overall number of dental caries, and served as a suitable matrix for subgingival air-polishing to replace traditional root scaling. Conclusions. Important differences were reported in the effect of individual polyols on oral health. The current review provides evidence demonstrating better efficacy of erythritol compared to sorbitol and xylitol to maintain and improve oral health.
International Journal of Toxicology | 2013
Andrey I. Nikiforov; Marisa O. Rihner; Alex K. Eapen; Jennifer A. Thomas
Rebaudioside D (Reb D) is one of the several glycosides found in the leaves of Stevia rebaudiana (Bertoni) Bertoni (Compositae) which has been identified as a potential sweetener. The metabolism of Reb A and Reb D was evaluated in various in vitro matrices (simulated gastrointestinal fluids, rat liver microsomes, and rat cecal contents) and through analysis of plasma collected from rats in a dietary toxicity study. Reb A and Reb D showed similar stability when exposed to simulated stomach and small intestine fluids, with susceptibility to hydrolytic degradation by enteric bacteria collected from the cecum. Incubations with rat liver microsomes indicated that neither compound is expected to be metabolized by the liver enzymes. Plasma concentrations of Reb D, Reb A, and/or the final hydrolysis product of each compound, free/conjugated steviol, were consistent between animals administered either Reb D or Reb A in the diet. A repeated exposure dietary toxicity study was conducted to compare the safety of Reb D, when administered at target exposure levels of 500, 1000, and 2000 mg/kg body weight (bw)/d to Sprague-Dawley rats for 28 days, to that of Reb A administered at a target exposure level of 2000 mg/kg bw/d. There were no treatment-related effects on the general condition and behavior of the animals and no toxicologically relevant, treatment-related effects on hematology, serum chemistry, or urinalysis. Macroscopic and microscopic findings revealed no treatment-related effects on any organ evaluated. Results were comparable between the group administered 2000 mg/kg/d Reb D and the group administered 2000 mg/kg/d Reb A.
Food and Chemical Toxicology | 2016
Borje Darpo; Thorir D. Bjornsson; Witty A. Brathwaite; Christine M. Crincoli; Alex K. Eapen; Gerald L. Fisher; Peter R. Kowey; Marvin P. Miller; Andrey I. Nikiforov; Marisa O. Rihner; Meijian Zhou
Enzymatically-synthesized (2R,4R)-monatin has, due to its pure sweet taste, been evaluated for potential use in foods. Non-clinical studies have shown that (2R,4R)-monatin is well tolerated at high dietary concentrations, is not genotoxic/mutagenic, carcinogenic, or overtly toxic. In a pharmacokinetic and metabolism study involving 12 healthy males, consumption of a single oral dose (2 mg/kg) of (2R,4R)-monatin resulted in a small reduction of heart rate and prolongation of the QTcF interval of 20-24 ms, corresponding to the time of peak plasma levels (t(max)). These findings were evaluated in a cross-over thorough QT/QTc study with single doses of 150 mg (2R,4R)-monatin, placebo and positive control (moxifloxacin) in 56 healthy males. Peak (2R,4R)-monatin plasma concentration (1720 ± 538 ng/mL) was reached at 3.1 h (mean tmax). The placebo-corrected, change-from-baseline QTcF (ΔΔQTcF) reached 25 ms three hours after dosing, with ΔΔQTcF of 23 ms at two and four hours. Using exposure response (QTc) analysis, a significant slope of the relationship between (2R,4R)-monatin plasma levels and ΔΔQTcF was demonstrated with a predicted mean QT effect of 0.016 ms per ng/mL. While similarly high plasma levels are unlikely to be achieved by consumption of (2R,4R)-monatin in foods, QTc prolongation at this level is a significant finding.
American Journal of Physiology-endocrinology and Metabolism | 2016
Angela Bonnema; Peter Decock; Alex K. Eapen; Douwina Bosscher
to the editor: We have read with interest the recently published work by Wolnerhanssen et al. ([7][1]) entitled “Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects”. The authors demonstrated the ability of erythritol and xylitol
Food and Chemical Toxicology | 2011
J. Hlywka; Witty A. Brathwaite; Marisa O. Rihner; Andrey I. Nikiforov; Alex K. Eapen
Food and Chemical Toxicology | 2013
J.J. Hlywka; Witty A. Brathwaite; Marisa O. Rihner; Andrey I. Nikiforov; Alex K. Eapen
Food and Chemical Toxicology | 2007
Alex K. Eapen; Christopher P. Chengelis; Nancy P. Jordan; Roxanne E. Baumgartner; Guo-Hua Zheng; Ting Liu Carlson
Regulatory Toxicology and Pharmacology | 2016
Ashley Roberts; Barry S. Lynch; Rebecca Rogerson; A.G. Renwick; Hua Kern; Matthew Coffee; Nicole Cuellar-Kingston; Alex K. Eapen; Christine M. Crincoli; George Pugh; Sachin Bhusari; Sidd Purkayastha; Michael Carakostas
Food and Chemical Toxicology | 2016
Christine M. Crincoli; Witty A. Brathwaite; Marisa O. Rihner; Andrey I. Nikiforov; Stephen B. Harris; Melanie A. Greeley; Alex K. Eapen